Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has earned an average rating of “Hold” from the fourteen ratings firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $14.2083.
A number of brokerages recently issued reports on ARDT. Wall Street Zen upgraded shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Royal Bank Of Canada decreased their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, March 9th. UBS Group increased their target price on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research report on Thursday, May 7th. Leerink Partners decreased their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Finally, Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th.
Check Out Our Latest Report on Ardent Health
Hedge Funds Weigh In On Ardent Health
Ardent Health Stock Performance
Shares of ARDT opened at $9.21 on Friday. The firm has a 50-day moving average price of $9.38 and a 200 day moving average price of $9.22. The firm has a market capitalization of $1.32 billion, a PE ratio of 9.69, a P/E/G ratio of 2.05 and a beta of 0.93. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. Ardent Health has a 52-week low of $8.07 and a 52-week high of $15.48.
Ardent Health (NYSE:ARDT – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. The firm had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, sell-side analysts anticipate that Ardent Health will post 1.12 earnings per share for the current fiscal year.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
Read More
- Five stocks we like better than Ardent Health
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
